Trials / Recruiting
RecruitingNCT07434089
Impact of C-Mill Rehabilitation on the Gut-Brain Axis in Parkinson's Disease
Gut-Brain Axis and Rehabilitation: Study on the Effects of C-Mill Technology on the Intestinal Microbiota of Parkinson's Disease Patients
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- IRCCS Centro Neurolesi Bonino Pulejo · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The GM-REHAB-2025 study aims to evaluate the impact of physiotherapy interventions using the C-Mill treadmill, with and without semi-immersive virtual reality, on gut microbiota and metabolic parameters in patients with Parkinson's disease. Three groups will be involved: one undergoing conventional physiotherapy, one treated with the C-Mill without virtual reality (VR), and one treated with C-Mill technology combined with VR. Clinical assessments and the collection of biological samples (stool, serum, and plasma) will be carried out at three time points: at baseline, at the end of treatment (21 days), and after 3 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | C-Mill technology treadmill equipped with semi-immersive VR | C-Mill treatment combined with semi-immersive virtual reality (VR). The VR component will feature visual obstacles, such as virtual traffic cones or country paths, in conjunction with audio-visual stimuli to promote engagement and guide movement. |
| DEVICE | C-Mill treatment without semi-immersive virtual reality (VR) | C-Mill treatment will be administrated as a standalone therapy, without the integration of virtual reality (VR). |
| OTHER | Conventional physiotherapy training | Will be carried under the manual guidance and supervision of a physiotherapist. The rehabilitation program will include weight-shifting exercises, as well as monopodal and bipodal balance exercises. |
Timeline
- Start date
- 2025-10-20
- Primary completion
- 2027-10-20
- Completion
- 2028-10-20
- First posted
- 2026-02-25
- Last updated
- 2026-02-25
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07434089. Inclusion in this directory is not an endorsement.